MEDNAX (MD) Reports In-Line Q3 EPS, Guides Q4 Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
MEDNAX Reports 2015 Third Quarter Adjusted EPS of $1.10
October 29, 2015 6:00 AM EDTExpects Fourth Quarter Adjusted EPS of $1.10 to $1.14
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- MEDNAX, Inc. (NYSE: MD), the national medical group specializing in neonatal and other pediatric services, anesthesia, maternal-fetal, pediatric cardiology and other physician and management services, today reported earnings of $0.97 per diluted share for the three months ended September 30, 2015, an increase of 13% over the prior-year period. On a non-GAAP basis, MEDNAX reported Adjusted EPS of $1.10, an increase of 15% over the prior-year period.
For the 2015 third quarter compared to the prior year period, MEDNAX reported:
Revenue growth of 15.3... More